Inventor · disambiguated record
Qi Jia
Also filed as: JIA QI
86 granted patents·41 pending applications·731 citations·filing 1996–2024
99Inventor score
Files withUNIGEN INC49UNIGEN PHARMACEUTICALS INC22GENENTECH INC14XENON PHARMACEUTICALS INC12JIA QI10
Top patents by PatentIndex Score
127 records- 0197US8933236B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Jan 13, 2015·50 cites·32 claims
- 0296US7514469B2Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agentUNIGEN PHARMACEUTICALS INC·Filed 2003·Granted Apr 7, 2009·72 cites·18 claims
- 0395US8952169B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Feb 10, 2015·25 cites·43 claims
- 0494US8034387B2Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairmentsUNIGEN INC·Filed 2007·Granted Oct 11, 2011·15 cites·8 claims
- 0593US7972632B2Identification of Free-B-Ring flavonoids as potent COX-2 inhibitorsUNIGEN PHARMACEUTICALS INC·Filed 2007·Granted Jul 5, 2011·20 cites·12 claims
- 0693US7767661B2Diarylalkanes as potent inhibitors of binuclear enzymesUNIGEN PHARMACEUTICALS INC·Filed 2008·Granted Aug 3, 2010·15 cites·9 claims
- 0793US7678772B27-hydroxy chromones as potent antioxidantsUNIGEN PHARMACEUTICALS INC·Filed 2005·Granted Mar 16, 2010·24 cites·10 claims
- 0892US9694002B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jul 4, 2017·11 cites·10 claims
- 0992US9546164B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2015·Granted Jan 17, 2017·13 cites·38 claims
- 1091US10857082B2Diarylalkanes as potent inhibitors of binuclear enzymesUNIGEN INC·Filed 2020·Granted Dec 8, 2020·2 cites·6 claims
- 1191US9771376B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 26, 2017·7 cites·19 claims
- 1291US8263606B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Sep 11, 2012·16 cites·25 claims
- 1391US8124134B2Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from AcaciaJIA QI·Filed 2006·Granted Feb 28, 2012·16 cites·16 claims
- 1491US7695743B2Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairmentsUNIGEN PHARMACEUTICALS INC·Filed 2007·Granted Apr 13, 2010·17 cites·8 claims
- 1591US7108868B2Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acaciaUNIGEN PHARMACEUTICALS INC·Filed 2002·Granted Sep 19, 2006·37 cites·6 claims
- 1690US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 1790US8535735B2Identification of free-B-ring flavonoids as potent COX-2 inhibitorsJIA QI·Filed 2012·Granted Sep 17, 2013·12 cites·52 claims
- 1890US2025099526A1Natural Preservatives and Antimicrobial Agents, Including Compositions ThereofUNIGEN INC·Filed 2024·Application pending·0 cites
- 1989US10434073B2Bakuchiol compositions for treatment of post inflammatory hyperpigmentationUNIGEN INC·Filed 2017·Granted Oct 8, 2019·6 cites·19 claims
- 2089US9844576B2Compositions and methods for managing weightUNIGEN INC·Filed 2013·Granted Dec 19, 2017·15 cites·1 claims
- 2189US8568799B2Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acaciaJIA QI·Filed 2012·Granted Oct 29, 2013·10 cites·18 claims
- 2289US8415370B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Apr 9, 2013·10 cites·13 claims
- 2389US8110555B27-hydroxy chromones as potent antioxidantsJIA QI·Filed 2010·Granted Feb 7, 2012·13 cites·21 claims
- 2489US7674830B2Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agentUNIGEN PHARMACEUTICALS INC·Filed 2003·Granted Mar 9, 2010·22 cites·2 claims
- 2589US7192611B2Identification of Free-B-Ring flavonoids as potent COX-2 inhibitorsUNIGEN PHARMACEUTICALS INC·Filed 2003·Granted Mar 20, 2007·32 cites·22 claims
- 2689US6884783B27-Hydroxy chromones as potent antioxidantsUNIGEN PHARMACEUTICALS INC·Filed 2002·Granted Apr 26, 2005·31 cites·12 claims
- 2788US11857657B2Diarylalkanes as potent inhibitors of binuclear enzymesUNIGEN INC·Filed 2020·Granted Jan 2, 2024·1 cites·4 claims
- 2887US10005724B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2015·Granted Jun 26, 2018·6 cites·11 claims
- 2987US9630929B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2012·Granted Apr 25, 2017·11 cites·29 claims
- 3087US8742109B2Synthetic methods for spiro-oxindole compoundsCADIEUX JEAN-JACQUES·Filed 2012·Granted Jun 3, 2014·12 cites·6 claims
- 3186US12161686B2Natural preservatives and antimicrobial agents, including compositions thereofUNIGEN INC·Filed 2022·Granted Dec 10, 2024·0 cites·20 claims
- 3286US8945518B2Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditionsJIA QI·Filed 2005·Granted Feb 3, 2015·4 cites·11 claims
- 3386US8592488B2Diarylalkanes as potent inhibitors of binuclear enzymesJIA QI·Filed 2010·Granted Nov 26, 2013·5 cites·20 claims
- 3485US9713596B2Bakuchiol compositions for treatment of post inflammatory hyperpigmentationHONG MEI FENG·Filed 2012·Granted Jul 25, 2017·10 cites·27 claims
- 3585US8049016B2Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymesNOVARTIS AG·Filed 2009·Granted Nov 1, 2011·7 cites·19 claims
- 3685US7531521B2Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditionsUNIGEN PHARMACEUTICALS INC·Filed 2004·Granted May 12, 2009·25 cites·10 claims
- 3784US11253486B2Bakuchiol compositions for treatment of post inflammatory hyperpigmentationUNIGEN INC·Filed 2020·Granted Feb 22, 2022·1 cites·16 claims
- 3884US8652535B2Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairmentsJIA QI·Filed 2011·Granted Feb 18, 2014·6 cites·15 claims
- 3984US8445696B2Synthetic methods for spiro-oxindole compoundsCADIEUX JEAN-JACQUES·Filed 2010·Granted May 21, 2013·9 cites·8 claims
- 4083US10548825B2Diarylalkanes as potent inhibitors of binuclear enzymesUNIGEN INC·Filed 2015·Granted Feb 4, 2020·2 cites·2 claims
- 4182US10981905B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Apr 20, 2021·1 cites·54 claims
- 4282US9695185B2Synthetic methods for spiro-oxindole compoundsXENON PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·3 cites·1 claims
- 4382US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 4482US8790724B2Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin careJIA QI·Filed 2011·Granted Jul 29, 2014·4 cites·35 claims
- 4581US10583161B2Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereofUNIGEN INC·Filed 2017·Granted Mar 10, 2020·1 cites·12 claims
- 4681US10125098B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Nov 13, 2018·2 cites·12 claims
- 4780US9126913B2Diarylalkanes as potent inhibitors of binuclear enzymesUNIGEN INC·Filed 2014·Granted Sep 8, 2015·2 cites·6 claims
- 4880US8729136B2Diarylalkanes as potent inhibitors of binuclear enzymesUNIGEN INC·Filed 2012·Granted May 20, 2014·2 cites·8 claims
- 4979US2023027219A1Skin Care Compositions and Methods of Use ThereofUNIGEN INC·Filed 2022·Application pending·0 cites
- 5079US2025183494A1Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense MechanismUNIGEN INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 127 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Qi Jia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →